Acute interstitial nephritis secondary to vedolizumab.

Simpson, Nicholas; Seenan, John Paul; Patel, Rajan; Kipgen, David

Simpson, Nicholas; Seenan, John Paul; Patel, Rajan; Kipgen, David.

Simpson N; Queen Elizabeth University Hospital, NHSGGC, Glasgow, UK nsimpson12@qub.ac.uk.
Seenan JP; Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK.
Patel R; Nephrology, Queen Elizabeth University Hospital, Glasgow, UK.
Kipgen D; Pathology, Beatson West of Scotland Cancer Centre, Glasgow, UK.

BMJ Case Rep ; 14(11)2021 Nov 19.

Article in English | MEDLINE | ID: covidwho-1526469

ABSTRACT

ABSTRACT

We present a patient with an acute kidney injury thought secondary to acute interstitial nephritis as a result of vedolizumab maintenance therapy for Crohn's disease. This appears to be a rare but serious side effect in patients receiving this treatment which clinicians should consider in the event of renal dysfunction.

Subject(s)

Crohn Disease; Nephritis, Interstitial; Antibodies, Monoclonal, Humanized/adverse effects; Crohn Disease/drug therapy; Humans; Nephritis, Interstitial/chemically induced

Keywords

Crohn's disease; acute renal failure; renal system; unwanted effects/adverse reactions

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Crohn Disease / Nephritis, Interstitial Type of study: Case report Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bcr-2021-243568

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google